Oxaliplatin based chemotherapy for advanced well-differentiated neuroendocrine tumors: A systematic review and meta-analysis

被引：0
|
作者：
Wang, Jian [1 ]
Wang, Xiangling [1 ]
Chu, Yunxia [1 ]
Li, Shuguang [1 ]
Hao, Jing [1 ]
机构：
[1] Shandong Univ, Dept Med Oncol, Qilu Hosp, Jinan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16240
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement
    Coriat, Romain
    Walter, Thomas
    Terris, Benoit
    Couvelard, Anne
    Ruszniewski, Philippe
    ONCOLOGIST, 2016, 21 (10): : 1191 - 1199
  • [42] Gemcitabine and Oxaliplatin Combination Chemotherapy for Metastatic Well-differentiated Neuroendocrine Carcinomas A Single-Center Experience
    Cassier, Philippe A.
    Walter, Thomas
    Eymard, Beatrice
    Ardisson, Philippe
    Perol, Maurice
    Paillet, Carole
    Chayvialle, Jean-Alain
    Scoazec, Jean-Yves
    Hervieu, Valerie
    Bohas, Catherine Lombard
    CANCER, 2009, 115 (15) : 3392 - 3399
  • [43] The efficacy and safety of sunitinib in patients with advanced well-differentiated pancreatic neuroendocrine tumors.
    Raymond, Eric
    Kulke, Matthew H.
    Qin, Shukui
    Schenker, Michael
    Cubillo, Antonio
    Lou, Wenhui
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Xu, Jianming
    Racz, Karoly
    Croitoru, Adina E.
    Khasraw, Mustafa
    Sedlackova, Eva
    Borbath, Ivan
    Ruff, Paul
    Oberstein, Paul Eliezer
    Ito, Tetsuhide
    Fernandez, Kathrine C.
    Rosbrook, Brad
    Fazio, Nicola
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [44] Angiogenic profiling in patients with advanced well-differentiated pancreatic neuroendocrine tumors treated with everolimus
    Cella, C. A.
    Spada, F.
    Galdy, S.
    Frezza, A. M.
    Catapano, M.
    Funicelli, L.
    Calleri, A.
    Zorzino, L.
    Mancuso, P.
    Radice, D.
    Fazio, N.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S449 - S449
  • [45] Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas
    Hai-Yan Chen
    Yao Pan
    Jie-Yu Chen
    Lu-lu Liu
    Yong-Bo Yang
    Kai Li
    Ri-Sheng Yu
    Guo-Liang Shao
    European Radiology, 2022, 32 : 8317 - 8325
  • [46] Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas
    Chen, Hai-Yan
    Pan, Yao
    Chen, Jie-Yu
    Liu, Lu-lu
    Yang, Yong-Bo
    Li, Kai
    Yu, Ri-Sheng
    Shao, Guo-Liang
    EUROPEAN RADIOLOGY, 2022, 32 (12) : 8317 - 8325
  • [47] Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis
    Cigrovski Berkovic, Maja
    Coppola, Alessandro
    Sesa, Vibor
    Mrzljak, Anna
    Lai, Quirino
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (07) : 759 - 769
  • [48] Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis
    Erfan Taherifard
    Muhammad Bakhtiar
    Mahnoor Mahnoor
    Rabeea Ahmed
    Ludimila Cavalcante
    Janie Zhang
    Anwaar Saeed
    BMC Cancer, 24
  • [49] Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis
    Taherifard, Erfan
    Bakhtiar, Muhammad
    Mahnoor, Mahnoor
    Ahmed, Rabeea
    Cavalcante, Ludimila
    Zhang, Janie
    Saeed, Anwaar
    BMC CANCER, 2024, 24 (01)
  • [50] Platinum-doublet chemotherapy for advanced gastroenteropancreatic neuroendocrine carcinoma: a systematic review and meta-analysis
    Akihiro Ohmoto
    Yu Fujiwara
    Nobuyuki Horita
    Kenji Nakano
    Shunji Takahashi
    Discover Oncology, 13
12345